# Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D

Study · id `cardio:ct-nct01442272` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01442272](<https://clinicaltrials.gov/study/NCT01442272>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01442272

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 174 participants.

## Technical summary

Registry record NCT01442272. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2012-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 174 participants (planned count; ClinicalTrials.gov record NCT01442272, source copy `cardio:ctgov-nct01442272-2012-05-21`, retrieved 2026-10-26)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT01442272, source copy `cardio:ctgov-nct01442272-2012-05-21`, retrieved 2026-10-26)
- Primary completion: 2012-10 (anticipated) (ClinicalTrials.gov record NCT01442272, source copy `cardio:ctgov-nct01442272-2012-05-21`, retrieved 2026-10-26)
- Completion: 2013-10 (anticipated) (ClinicalTrials.gov record NCT01442272, source copy `cardio:ctgov-nct01442272-2012-05-21`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT01442272, source copy `cardio:ctgov-nct01442272-2012-05-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01442272-2012-05-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D
- Acronym: NEFROVID2010
- Condition: Kidney Failure, Chronic
- Condition: Disorder of Vitamin D
- Intervention (Drug): Hidroferol®
- Intervention (Drug): Paricalcitol: Zemplar®
- Intervention (Drug): Habitual medication
- Lead sponsor: Hospital Universitario de Canarias
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: e55b265873081dc2460c88d6fcafbca3d1120dcaedd140b1b03c1441d83b0d8a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
